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ABSTRACT

ARTICLE HISTORY

Background: The Brugada pattern is identified on the EKG by a coved ST-segment elevation
accompanied by a negative T wave in the early precordial leads in the absence of a cardiac
structural abnormality. Brugada pattern and Brugada syndrome should be differentiated, as
the latter is associated with an increased risk of sudden cardiac death.
Methods: The literature was searched using multiple databases to identify all the articles on
Brugada pattern. Data were screened and analyzed by independent authors.
Results: Sixty articles, comprising 71 patients, were included in the study. The mean age of
patients was 42.6 years, with a higher prevalence of Brugada pattern in men (83%) than
women (17%). The most frequent findings associated with Brugada pattern was fever (83%).
Other less common presentations included cough (21%), sore throat (10%), syncope (18%),
abdominal pain (8%), and chest pain (7%). Comorbidities included pneumonia (30%), upper
respiratory tract infections (14%) and smoking (14%). Among treatment modalities, 39% of
patients had ICD placement performed, 44% received antibiotics, while 14% had supportive
care. Adenosine was given to 3% of patients, while other antiarrhythmics like milrinone,
amiodarone, sotalol, procainamide, flecainide, and nitroglycerin were given to 1% of patients.
Most patients with Brugada syndrome had a satisfactory outcome, with only 4% mortality
rate(WHAT ABOUT THE OTHER 11%?). Out of the 71 patients, 3% had persistent Brugada
patterns, while 86% of patients recovered completely. There was no significant effect of ICD
on mortality or Brugada pattern resolution (p 0.37).
Conclusion: Our study shows that fever is the main reason for unmasking the Brugada
pattern in patients with this channelopathy. ICD placement in such patients is not recommended as it has no mortality benefits.
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1. Introduction
The Brugada pattern was first described in 1992 by
Brugada, characterized by ST-segment elevation
accompanied by a negative T wave in the early precordial leads without any cardiac structural abnormality [1]. In 1996, Yan and Antzelevitch proposed that
this ST-segment elevation and right bundle branch
block (RBBB) appearance had a cellular basis for the
development of life-threatening arrhythmias [2]. This
theory further confirmed by Kobayashi et al. and
Miyazaki et al. [3–6] This review aims to summarize
the known literature specifically on the Brugada pattern and also highlights the distinguishing features of
Brugada pattern and Brugada syndrome.

2. Materials and methods
A literature search for relevant articles was performed
using MEDLINE (PubMed, Ovid), Embase, and
Cochrane databases. A total of 60 articles were selected
after initial screening and duplicates removal. The
authors extracted data into an excel sheet identifying
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presentation, risk factors, diagnostic modalities, management, and outcome of patients with Brugada pattern.

3. Results
A total of 71 patients were identified from the
included 60 articles. The mean age was 42.6 years.
Approximately 35% of the patients were 50 years or
older. Of the reported cases, 83% were males, and
17% were females. Overall, the most common presentation was fever in 83% of patients. Upper respiratory symptoms were also reported frequently,
including cough in 21%, sore throat in 10%. Besides
these, syncope was present in 18%, abdominal pain in
8%, chest pain in 7%, arthralgia in 4%, nausea and
vomiting in 4%, and pleuritic chest pain in 3%. The
most common associated comorbidity was pneumonia, present in 30% of patients. An upper respiratory
tract infection was present in 14% of the patients.
Ventricular fibrillation was present in 8% and ventricular tachycardia in 4%. Other comorbidities are
shown in Table 1
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Table 1. This table depicts the epidemiology, most common presenting symptoms, and comorbidities
associated with presentation of Brugada pattern.
Epidemiology (n = 71)
Mean age of presentation
Age 50 and above
Male sex 83%
Associated Comorbidities
Pneumonia
Upper respiratory tract infection
Smoking
Ventricular fibrillation
Hypertension
Dyslipidemia
Malaria

Percent patients
42.6 years
35%
83%
Percentage (n = 71)
30%
14%
11%
8%
7%
6%
4%

Thirty nine percent of patients had an ICD placed
for the Brugada pattern. Forty four percent of
patients received antibiotics. As many of the patients
presented with fever or an infection. One patient
underwent defibrillation. Three percent received adenosine, and 1% received milrinone, amiodarone, sotalol, procainamide, flecainide or nitroglycerine. This is
shown in Table 2
Most of the patients with the Brugada pattern had
a good outcome. 86% of the patients recovered, while
4% died and 3% had persistent brugada pattern, no
outcome data was available in 7% patients.
The clinical outcomes in these patients were further
assessed based on presentation, comorbidities, and
management. One important characteristic that was
evaluated as if there was any association of ICD placement with better outcomes. A total of 27 patients had an
ICD placed, and out of these patients, 26 (96%) recovered, while one patient had persistent Brugada pattern.
There were no deaths recorded. On the other hand, in
patients that did not receive an ICD, 3 (7%) of the
patients died, 39 (88%) recovered, and 2 (5%) patients
had persistent Brugada pattern. Even though the rate of
death was much higher (6.8% vs. 0%) in patients who
did not receive an ICD, this difference was not statistically significant (p = 0.372). Figure 1
The outcomes of patients with different presentations, associations, co-morbidities, and management
options were analyzed, as depicted in Table 3. There
was no statistically significant association, based on
chi-square test, between different outcomes and any
of the above-described feature.
Table 2. Management of our patient population
with Brugada syndrome.
Management
Antibiotics
Implantable Cardiac Defibrillators
Supportive care
Analgesics
Steroids
Cardioversion, defibrillation
Milrinone, adenosine, amiodarone,
sotalol, procainamide, flecainide
Laparoscopic cholecystectomy
Nitroglycerine

Percentage
(n = 71)
44%
39%
14%
10%
2%
1% each
1% each
1%
1%

Presenting symptoms (n = 71)
Fever
Cough
Syncope
Sore throat
Abdominal pain
Chest pain
Arthralgia
Vomiting and nausea
Pleuritic chest pain
Altered mental status
Seizures,HSM, Diarrhea

83%
21%
18%
10%
8%
7%
4%
4%
3%
3%
1% each

4. Discussion
Our analysis indicates Brugada pattern is
a relatively benign condition mostly unmasked by
fever and has favourable outcomes if the underlying conditions are treated. These patients have
channelopathy just like brugada syndrome patients
but they do not have a history of sudden cardiac
death in their family nor have been symptomatic in
life, differentiating them from brugada syndrome.
As per our study, patients with brugada pattern do
not need ICD placement or antiarrhythmic medications. The brugada pattern resolves with the
management of the underlying condition. Brigada
pattern patients do not have symptoms, so they are
usually unaware of their condition unless diagnosed incidentally on EKG.

5. Clinical presentation
Brugada pattern typically is unmasked by fever due to
any cause, mostly in association with a chest infection. Our study found fever was associated with
Brugada pattern in 83% of presenting patients.
Further, we found the most frequent association was
with pneumonia (30%) and upper respiratory tract
infection (14%). Other findings associated with
Brugada pattern included cough in 21% of the individuals, sore throat in 10%, syncope in 18%, abdominal pain in 8% and chest pain in 7%.
Brugada pattern typically presents during adulthood (42.6% in our study). A study of 384 patients
showed its occurrence in men predominantly (70%)
[7]. Our study showed a higher prevalence in males
(83%) compared to females (17%).

6. Molecular genetics and cellular
mechanisms
Brugada syndrome shows an autosomal dominant
mode of transmission. In 1998, Chen et al. demonstrated the link of Brugada syndrome to the alpha
subunit of the cardiac sodium channel gene (SCN5A
gene) [8]. The loss of function of this gene can be
caused by a failure of expression of the channel,
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Figure 1. This figure depicts the outcomes in patients who received and those who did not receive an ICD.
Table 3. This table depicts the association between different outcomes and different patient
characteristics.
Characteristic
Presentations
Sex
Fever
Syncope
Pneumonia/URI
Associations/co-morbidities
Family history of Brugada
Family history of SCD
Hypertension
Smoking
Management
ICD
Antibiotics

Recovery (percentages)
92%
90%
91%
95%

vs
vs
vs
vs

90% (males vs females)
100% (fever vs no fever)
92% (syncope vs no syncope)
88%

P-value
(chi-square test)
0.49
0.51
0.52
0.14

71% vs 94% (family history vs no family history)
80% vs 92% (family history vs no family history)
100% vs 91% (Hypertension vs no Hypertension)
88% vs 92% (smoking vs no smoking)

0.13
0.17
0.82
0.39

96% vs 89%
94% vs 0.9%

0.37
0.22

accelerated inactivation of the pathway, inactivation
of the channel to an intermediate state with a slow
recovery, or a shift in voltage and time-dependent
sodium channel activation, inactivation, or reactivation [9]. It was observed that the accelerated inactivation of sodium channels occurred at temperatures
above the physiologic range suggesting the possible
mechanism for Brugada pattern in a febrile state [10].
In 2002, Antzelevitch et al. identified patients of the
Brugada pattern exhibiting fever-induced ventricular
tachycardia (VT) [11].
Various studies conducted to understand the cellular mechanisms of Brugada pattern suggest
a rebalancing of active currents at the end of phase 1
causing the ST-segment elevation or J wave observed
in the Brugada pattern [12]. The accentuation of the
J wave leads to a saddleback configuration of the
repolarization waves. As the notch becomes more prominent due to the prolongation of an epicardial action
potential, the direction of repolarization across the RV
wall and transmural voltage gradient is reversed. This
leads to a typical dome-like ST segment elevation and
T wave inversion. (Figure 2)

7. Diagnosis
Brugada pattern is characterized by three types of repolarization patterns in the right precordial ECG leads.
Out of these three patterns, type 1 pattern is diagnostic
of Brugada, and it consists of a coved ST-segment
elevation of more than 2 mm (0.2 mV) followed by
T wave inversion. Type 2 ECG pattern of Brugada
typically shows a saddleback appearance with an STsegment elevation of ≥2 mm, a trough showing ≥1 mm
ST elevation, and a positive or biphasic T wave [8]. In
type 3, there is an ST-segment elevation of <1 mm with
a saddleback or coved appearance. The definitive diagnosis in types 2 and 3 is made by the presence of type 1
ST-segment elevation in more than one right precordial
lead (V1 to V3) in the presence or absence of a sodium
channel blocking drug [12]. The three types of Brugada
patterns are illustrated in the figure below. (Figure 2)
It is essential to exclude other factors that could lead to
the these ECG abnormalities, such as atypical RBBB, left
ventricular hypertrophy, acute pericarditis, dissecting
aortic aneurysm, electrolyte abnormalities, or mechanical
compression of the right ventricular outflow tract
(RVOT) [12].
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Figure 2. EKG of a patient with Brugada syndrome with three characteristic patterns. The left panel shows a type 1 ECG,
whereas the middle and right panels show type 2 and 3 ECGs.

8. Management
Over the past few years, a considerable amount of progress has been observed in the diagnosis and characterization of Brugada pattern and syndrome. However, the
same cannot be said about its management. For Brugada
syndrome, an ICD has proved to be the only definitive
treatment [13]. However, its use is riddled with limitations. It is not a feasible treatment option in infants and
young children, and in some parts of the world, its
implantation is extremely expensive. Patients with
Brugada pattern, however, require supportive care and
treatment of febrile illness. There was no significant benefit of ICD or pacemaker noted in our review on the
Brugada pattern
Other options in Brugada syndrome are pharmacological therapy, including quinidine to restore the epicardial action potential dome, leading to normalization of
the ST segment and preventing phase 2 reentry and
development of VT [14]. However, its use in the prevention of sudden death has not been established. Other
antiarrhythmic drugs such as amiodarone and betablockers have been observed to be ineffective, whereas
class IA antiarrhythmic such as procainamide and class
IC antiarrhythmics such as flecainide and propafenone
are contraindicated [15]. Our study, however, focused on
the management of the Brugada pattern only and
revealed that 39% of patients had ICD placement

performed for Brugada pattern due to other compelling
indications (family history of sudden deaths, low ejection
fraction). Most patients (44%) were started on antibiotics
for the treatment of underlying febrile illness while supportive care was given to 14% of patients. Only a few
patients had antiarrhythmic therapies, adenosine (3%)
and milrinone, amiodarone, sotalol, procainamide, flecainide, and nitroglycerin were given to 1% of patients.

9. Outcome
According to our study, most patients with the Brugada
pattern had a satisfactory outcome, with a mortality rate
of only 4%. Out of the 71 patients, 3% had persistent
Brugada patterns, while 86% of patients recovered completely. When the recovery pattern of the different
treatment modalities was assessed, 96.3% of patients
with ICD placement had a complete recovery, while in
patients who underwent conservative treatment, 88.6%
recovered completely, 4.5% had persistent Brugada pattern, and 6.8% (n = 3) patients died.

10. Conclusions
Brugada syndrome is associated with a high incidence of
sudden deaths in adults with structurally healthy hearts
and should be managed with ICD, pacemaker, or
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antiarrhythmic medications. Brugada pattern, on the
other hand, is a benign condition usually unmasked by
fever and can be reversed by alleviating the cause of
illness. ICD has no mortality benefit in the Brugada
pattern.
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